Johnson & Johnson (JNJ)

146.40
+1.04(+0.72%)
  • Volume:
    2,276
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    145.10 - 146.90
  • Type:Equity
  • Market:Germany
  • ISIN:US4781601046
  • WKN:853260

JNJ Overview

Prev. Close
145.36
Day's Range
145.1-146.9
Revenue
-
Open
145.5
52 wk Range
116.12-147.08
EPS
-
Volume
2,276
Market Cap
381.91B
Dividend (Yield)
3.59
(2.47%)
Average Vol. (3m)
5,909
P/E Ratio
-
Beta
-
1-Year Change
18.18%
Shares Outstanding
2,632,482,092
Next Earnings Date
-
What is your sentiment on Johnson & Johnson Co?
or
Market is currently closed. Voting is open during market hours.

Johnson & Johnson Co News

Johnson & Johnson Co Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

Johnson & Johnson Co Company Profile

Johnson & Johnson Co Company Profile

Employees
134500

Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON’S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women’s health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Read More
  • should look at evfm! non hormone birth control sales up 100% only use when needed for birth control...no pills
    0
    • https://www.cnbc.com/2021/07/21/drug-distributors-jj-reach-landmark-26-billion-opioid-settlement-.html
      0
      • sell for target 167.5
        2
        • Pfizer and moderna just hate on JNJ
          0
          • buy
            2
            • Time to buy...
              0
              • The European Union (EU), which has ordered 200 million doses of the vaccine developed by the US-based pharmaceutical company Johnson & Johnson (J&J), against Covid-19, J&J has 55 million doses, which must be delivered by the end of June. It has been announced that there will be a delay in the delivery of million doses of vaccine.
                1
                • juj
                  0
                  • 0356000113
                    0
                    • European Health Regulators Add Blood Clot Warning to J&J’S Covid-19 Vaccine
                      4
                      • Nice earnings
                        0
                        • Is there any way to how can i safe from corona
                          0
                          • stay away from humans
                            0
                        • https://investors.vaxart.com/static-files/560116e8-db25-42df-865e-0ed57b8d129a
                          0
                        • earnings are arriving, the market thinks they wil grow so the stock does not go down.
                          0
                          • Surprised it is not down by a lot after the horrible bad news.
                            0
                            • They can easily buy their own stock they ade sitting on bllions
                              0
                          • Going down
                            0
                            • BREAKING NEW ALERT: CDC and FDA recommend US pause use of Johnson &Johnson's Covid-19 vaccine over blood clot concerns.
                              0
                              • BREAKING NEW ALERT: CDC and FDA recommend US pause use of Johnson & Johnson's Covid-19 vaccine over blood clot concerns.
                                0
                                • https://www.cnbc.com/2021/04/13/us-regulators-reportedly-call-for-pause-in-use-of-johnson-johnson-vaccine-due-to-clotting-issues.html
                                  0
                                  • Buy pfizer
                                    2
                                    • Why would you do that? Max ever was 49$ and then down. Jnj always up... maybe jnj is not the super stock bud Pfizer is no alternative...
                                      2
                                  • J&J vaccine manufacturing error affects 15m doses
                                    5
                                    • Mixup of jnj and A Zenica drug substance...!? FDA will be all over the place to investigate, could end up in a warning letter for the third party manufacturer, too little supervision from JnJ?
                                      0
                                  • giving huge pay raises to execs amid massive litigation and lawsuits for thier role in the oppiod crisis and cancer causing Talcolm powder
                                    0
                                    • They have no rol in that whatsoever, in the contrary, ceo tries to minimise cost and did that not to bad sofar.
                                      0
                                    • 0
                                  • another black eye for j and j investors I am liquidating it is going down guaranteed
                                    0
                                    • Why it will go back
                                      0
                                    • looks like I was wrong again
                                      0
                                    • Bro I think it will not go down anymore because j&j vaccine will be distributed to Africa and Europe soon and this news I think it will go up more and more
                                      0
                                  • wow all the way back now what
                                    0
                                    • crazy stock novanax down 30
                                      0
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.